Song Ding, Colin P. O'Banion, Joshua G. Welfare, David S. Lawrence
文献索引:10.1016/j.chembiol.2018.03.003
全文:HTML全文
Cell-based drug delivery systems offer the prospect of biocompatibility, large-loading capacity, longin vivolifespan, and active targeting of diseased sites. However, these opportunities are offset by an array of challenges, including safeguarding the integrity of the drug cargo and the cellular host, as well as ensuring that drug release occurs at the appropriate time and place. Emerging strategies that address these, and related, issues, are described herein.
The Rheumatoid Arthritis-Associated Citrullinome
2018-04-05 [10.1016/j.chembiol.2018.03.002] |
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a ...
2018-04-05 [10.1016/j.chembiol.2018.03.005] |
The O-GlcNAc Transferase Intellectual Disability Mutation L2...
2018-03-29 [10.1016/j.chembiol.2018.03.004] |
Targeting Phosphopeptide Recognition by the Human BRCA1 Tand...
2018-03-29 [10.1016/j.chembiol.2018.02.012] |
Bacterial Alkaloid Biosynthesis: Structural Diversity via a ...
2018-03-29 [10.1016/j.chembiol.2018.02.013] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved